@article{78a5dd93700a41b6a5fae9bd3290d1f6,
title = "The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: Results from the international metastatic renal cell cancer database consortium",
author = "Schutz, {Fabio A.B.} and Wanling Xie and Frede Donskov and Monica Sircar and McDermott, {David F.} and Rini, {Brian I.} and Neeraj Agarwal and Pal, {Sumanta Kumar} and Sandy Srinivas and Christian Kollmannsberger and North, {Scott A.} and Wood, {Lori A.} and Ulka Vaishampayan and Tan, {Min Han} and MacKenzie, {Mary J.} and Lee, {Jae Lyun} and Rha, {Sun Young} and Takeshi Yuasa and Heng, {Daniel Y.C.} and Choueiri, {Toni K.}",
note = "Funding Information: Financial disclosures: Toni K. Choueiri certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Daniel Y.C. Heng has advisory roles at Aveo, Pfizer, Novartis, and Bayer. Mary J. Mackenzie has advisory roles at Novartis and Pfizer, and has received research funding from both. Lori A. Wood has advisory roles at Pfizer and Novartis, and has received research funding from Pfizer, Novartis, and GlaxoSmithKline. Ulka Vaishampayan has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. Sun-Young Rha has advisory roles at Novartis, Pfizer, and GlaxoSmithKline, and has received research funding from Novartis and Bayer Korea. Frede Donskov has received research funding from Novartis. Christian Kollmannsberger has advisory roles at Pfizer, Novartis, and GlaxoSmithKline, and has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. Brian I. Rini has advisory role at Pfizer, GlaxoSmithKline, Aveo, Bayer, Onyx, and has received research funding from GlaxoSmithKline and Pfizer. Sandy Srinivas has advisory roles at Pfizer, Novartis, and Genentech. Scott A. North has an advisory role Pfizer, Novartis, Bayer, and GlaxoSmithKline. Toni K. Choueiri has received research funding from Pfizer and has advisory roles at Aveo, Pfizer, Novartis, GlaxoSmithKline, Genentech, Bayer, and Onyx. The other authors declare that they have no conflicts of interest. ",
year = "2014",
month = apr,
doi = "10.1016/j.eururo.2013.10.013",
language = "English",
volume = "65",
pages = "723--730",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",
}
